Insulin does not stimulate protein synthesis acutely in prepubertal children with insulin-dependent diabetes mellitus

M G Vogiatzi1, K S Nair, P R Beckett

  • 1Department of Pediatrics, Baylor College of Medicine, Houston, Texas 77030, USA.

Insights

Insulin treatment in children with type 1 diabetes reduces protein breakdown but does not stimulate protein synthesis. This finding in children mirrors adult responses, indicating insulin

Area of Science:

  • Pediatric Endocrinology
  • Metabolic Research
  • Diabetes Mellitus Type 1

Background:

  • Insulin's role in protein metabolism differs between adult and young subjects.
  • Adults with type 1 diabetes show decreased protein loss with insulin, mainly via reduced breakdown.
  • Rodent studies suggest insulin may stimulate protein synthesis in young, growing individuals.

Purpose of the Study:

  • To investigate if insulin stimulates protein synthesis in prepubertal children with insulin-dependent diabetes mellitus.
  • To compare insulin's effect on protein metabolism in growing children versus adults and young rodents.

Main Methods:

  • Studied five prepubertal children with type 1 diabetes (aged 8.6-11.25 years).
  • Measured leucine kinetics using L-[1-13C]leucine infusion during insulin deprivation and administration.
  • Analyzed serum insulin, beta-hydroxybutyrate, and free fatty acid concentrations.

Main Results:

  • Insulin treatment significantly reduced protein breakdown (Leucine Ra) and leucine oxidation.
  • Insulin administration normalized blood glucose levels and decreased ketone and fatty acid levels.
  • Protein synthesis (nonoxidative leucine disposal) was not significantly affected by insulin treatment.

Conclusions:

  • Acute insulin therapy in growing prepubertal children with type 1 diabetes reduces net protein loss.
  • This reduction is primarily achieved by inhibiting protein breakdown, not by stimulating protein synthesis.
  • The effect of insulin on protein metabolism in growing children is similar to that observed in adults.

Related Concept Videos

Insulin Secretory Vesicles01:05

Insulin Secretory Vesicles

Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
Hormones Regulating Blood Glucose01:16

Hormones Regulating Blood Glucose

Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion01:27

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion

The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are co-secreted in...
Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but this inhibition is released...
Insulin: Biosynthesis, Chemistry, and Preparation01:25

Insulin: Biosynthesis, Chemistry, and Preparation

The endoplasmic reticulum (ER) of pancreatic β-cells synthesizes preproinsulin, which consists of a signal peptide, A and B chains, and a C-peptide. Preproinsulin is then cleaved and folded into proinsulin, which translocates to the Golgi apparatus for sorting and packaging into secretory granules. In these granules, enzymatic clipping generates insulin and C-peptide.
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment primarily uses...
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...